US Stock Market Closed

Dashboard

Assertio Therapeutics, Inc. (ASRT)

Current

- (-)

After Hours

Rating & Fair Value

Fair Value Premium lock
Institutional Holdings

H

Financial Strength

H

Sustainable Growth

B

Industry Comparison

H

Management & Equity

B

Analyst Opinion

B

Leverage & Liquidity

S

Fundamental Variables

B

Rating Performance

FV Performance

*There is a current rating on the stock that is included in these numbers based on its performance so far

About

Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL.

CEO

Arthur Joseph Higgins

Employees

125

Industry

-

Sector

-

Headquarters

Lake Forest

Exchange

NASDAQ

Summary Stats

Market Cap

125M

Revenue

121M

Net Income

3.24M

EPS

$0.07

Price-to-Earnings

38.37

Price-to-Book

1.12

Debt-to-Equity

2.03

News

Analyst Ratings

Price targets projected by 2 analysts

High

$3.00

Average

$2.48

Low

$1.00

Ratings calculated by 2 analysts

Buy

2

Hold

0

Sell

0

Last Dividend

Amount

-

Dividend Date

-

Frequency

-

Dividend Yield

Earnings

Most Recent Earnings

Last Earnings for Q1 2022

Last Earnings

Above by $0.29

Actual

$0.38 +322.2%

Consensus

0.09

Report Date

Year Ago

0.12

Year Ago Change %

Up 216%

Actual vs Estimates

XX

xxx

Upcoming Estimates Unavailable

Expected EPS
-

-

Actual EPS
-

--

Competitors

star Favorites